Drug Co. Says Exclusion Doesn't Bar Subpoena Coverage

By Emily Enfinger · August 28, 2023, 3:17 PM EDT

A drug development company born out of a merger is once again seeking coverage for expenses it advanced to two of its former officers in connection with U.S. Securities and Exchange...

To view the full article, register now.